day101
day one biopharmaceutical
['firefly-1', 'dayone']
 has reported the latest data from its registrational phase 2 firefly-1 trial at #asco23. based on the impressive results, the company has initiated a rolling new drug application with fda. canaan s julie grant is a board member. #cancer 
We’re an early-stage VC firm that invests in entrepreneurs with visionary ideas who want to make a difference in technology and healthcare.